Cargando…

Significant Synergistic Effect of Peroxisome Proliferator–Activated Receptor γ C-2821T and Diabetes on the Risk of Ischemic Stroke

OBJECTIVE: To explore the relationship between the genetic polymorphisms of PPARγ (Pro12Ala, C1431T, and C-2821T) and the risk of ischemic stroke and to investigate whether these genetic polymorphisms of PPARγ would modify the risk of ischemic stroke among patients with hypertension or diabetes. RES...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Fang-I, Lo, Wei-Cheng, Lin, Huey-Juan, Hsieh, Yi-Chen, Lien, Li-Ming, Bai, Chyi-Huey, Tseng, Hung-Pin, Chiou, Hung-Yi
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768222/
https://www.ncbi.nlm.nih.gov/pubmed/19651920
http://dx.doi.org/10.2337/dc09-0717
_version_ 1782173455881338880
author Hsieh, Fang-I
Lo, Wei-Cheng
Lin, Huey-Juan
Hsieh, Yi-Chen
Lien, Li-Ming
Bai, Chyi-Huey
Tseng, Hung-Pin
Chiou, Hung-Yi
author_facet Hsieh, Fang-I
Lo, Wei-Cheng
Lin, Huey-Juan
Hsieh, Yi-Chen
Lien, Li-Ming
Bai, Chyi-Huey
Tseng, Hung-Pin
Chiou, Hung-Yi
author_sort Hsieh, Fang-I
collection PubMed
description OBJECTIVE: To explore the relationship between the genetic polymorphisms of PPARγ (Pro12Ala, C1431T, and C-2821T) and the risk of ischemic stroke and to investigate whether these genetic polymorphisms of PPARγ would modify the risk of ischemic stroke among patients with hypertension or diabetes. RESEARCH DESIGN AND METHODS: The case-control study was conducted with 537 ischemic stroke patients and 537 control subjects. A structured questionnaire was used to collect information on conventional cardiovascular risk factors and laboratory results. The genetic polymorphisms of PPARγ were determined by PCR–restriction fragment–length polymorphism. RESULTS: A significant interaction was seen between the −2821C allele and diabetes but not between this allele and hypertension. A markedly elevated risk of ischemic stroke (odds ratio 9.7) was found in the subjects with diabetes and the −2821C allele compared with that in those without these two risk factors. CONCLUSIONS: The −2821C allele of PPARγ was a strong predictor of ischemic stroke for diabetic patients.
format Text
id pubmed-2768222
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-27682222010-11-01 Significant Synergistic Effect of Peroxisome Proliferator–Activated Receptor γ C-2821T and Diabetes on the Risk of Ischemic Stroke Hsieh, Fang-I Lo, Wei-Cheng Lin, Huey-Juan Hsieh, Yi-Chen Lien, Li-Ming Bai, Chyi-Huey Tseng, Hung-Pin Chiou, Hung-Yi Diabetes Care Original Research OBJECTIVE: To explore the relationship between the genetic polymorphisms of PPARγ (Pro12Ala, C1431T, and C-2821T) and the risk of ischemic stroke and to investigate whether these genetic polymorphisms of PPARγ would modify the risk of ischemic stroke among patients with hypertension or diabetes. RESEARCH DESIGN AND METHODS: The case-control study was conducted with 537 ischemic stroke patients and 537 control subjects. A structured questionnaire was used to collect information on conventional cardiovascular risk factors and laboratory results. The genetic polymorphisms of PPARγ were determined by PCR–restriction fragment–length polymorphism. RESULTS: A significant interaction was seen between the −2821C allele and diabetes but not between this allele and hypertension. A markedly elevated risk of ischemic stroke (odds ratio 9.7) was found in the subjects with diabetes and the −2821C allele compared with that in those without these two risk factors. CONCLUSIONS: The −2821C allele of PPARγ was a strong predictor of ischemic stroke for diabetic patients. American Diabetes Association 2009-11 2009-08-03 /pmc/articles/PMC2768222/ /pubmed/19651920 http://dx.doi.org/10.2337/dc09-0717 Text en © 2009 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details.
spellingShingle Original Research
Hsieh, Fang-I
Lo, Wei-Cheng
Lin, Huey-Juan
Hsieh, Yi-Chen
Lien, Li-Ming
Bai, Chyi-Huey
Tseng, Hung-Pin
Chiou, Hung-Yi
Significant Synergistic Effect of Peroxisome Proliferator–Activated Receptor γ C-2821T and Diabetes on the Risk of Ischemic Stroke
title Significant Synergistic Effect of Peroxisome Proliferator–Activated Receptor γ C-2821T and Diabetes on the Risk of Ischemic Stroke
title_full Significant Synergistic Effect of Peroxisome Proliferator–Activated Receptor γ C-2821T and Diabetes on the Risk of Ischemic Stroke
title_fullStr Significant Synergistic Effect of Peroxisome Proliferator–Activated Receptor γ C-2821T and Diabetes on the Risk of Ischemic Stroke
title_full_unstemmed Significant Synergistic Effect of Peroxisome Proliferator–Activated Receptor γ C-2821T and Diabetes on the Risk of Ischemic Stroke
title_short Significant Synergistic Effect of Peroxisome Proliferator–Activated Receptor γ C-2821T and Diabetes on the Risk of Ischemic Stroke
title_sort significant synergistic effect of peroxisome proliferator–activated receptor γ c-2821t and diabetes on the risk of ischemic stroke
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768222/
https://www.ncbi.nlm.nih.gov/pubmed/19651920
http://dx.doi.org/10.2337/dc09-0717
work_keys_str_mv AT hsiehfangi significantsynergisticeffectofperoxisomeproliferatoractivatedreceptorgc2821tanddiabetesontheriskofischemicstroke
AT loweicheng significantsynergisticeffectofperoxisomeproliferatoractivatedreceptorgc2821tanddiabetesontheriskofischemicstroke
AT linhueyjuan significantsynergisticeffectofperoxisomeproliferatoractivatedreceptorgc2821tanddiabetesontheriskofischemicstroke
AT hsiehyichen significantsynergisticeffectofperoxisomeproliferatoractivatedreceptorgc2821tanddiabetesontheriskofischemicstroke
AT lienliming significantsynergisticeffectofperoxisomeproliferatoractivatedreceptorgc2821tanddiabetesontheriskofischemicstroke
AT baichyihuey significantsynergisticeffectofperoxisomeproliferatoractivatedreceptorgc2821tanddiabetesontheriskofischemicstroke
AT tsenghungpin significantsynergisticeffectofperoxisomeproliferatoractivatedreceptorgc2821tanddiabetesontheriskofischemicstroke
AT chiouhungyi significantsynergisticeffectofperoxisomeproliferatoractivatedreceptorgc2821tanddiabetesontheriskofischemicstroke